Use of weight loss agents in the treatment of obesity: comparison of adverse effects in the use of orlistat versus sibutramine. Research, Society and Development, [S. l.], v. 11, n. 13, p. e415111335776, 2022. DOI: 10.33448/rsd-v11i13.35776. Disponível em: https://rsdjournal.org/rsd/article/view/35776. Acesso em: 5 dec. 2025.